DB06449InvestigationalSmall molecule
Investigated for use/treatment in inflammatory disorders (unspecified), crohn's disease, and rheumatoid arthritis.
- Primary indication
- Investigated for use/treatment in inflammatory disorders (unspecified), crohn's disease, and rheumatoid arthritis.Curator reviewed
- Code names
- SCH-52000
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of February 21, 2021
Which companies are running trials of Ilodecakin, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account